Sometime before September 2034, if Congress gets its way, a U.S. Navy attack submarine will put to sea carrying a weapon the ...

Millions are using the AI tool as a form of low cost therapy. So Dr Aaron Balick decided to turn the tables on his LLM ...

Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center registrational trial for SENTI-202, building off ...

Hyundai lit a fire under the performance EV world when it dropped the Ioniq 5 N a couple of years back. Not only was it the South Korean brand’s first crack at a high-performance electric car, it was ...

In this parody of the true crime genre, a mother with murderous tendencies reflects on the hard work and thankless sacrifices that go into parenting. By Dina Gachman When Mother’s Day rolls around, ...

The Atlanta singer’s debut is a well-polished R&B fantasy that highlights her exceptional voice. No score yet, be the first to add. 0.0 Jai’Len Josey’s voice fills in those gaps, though. She can ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB functional cure, with a PDUFA target date of October 26, 2026. Current ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for bepirovirsen, an ...

Compass Pathways (NASDAQ:CMPS) is one of the small cap stocks with the highest upside potential. On April 24, Compass Pathways announced that the US FDA granted a rolling review for its NDA and ...